Reported Sep 25, 2019 · Terminated

Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick…

Aurolife Pharma, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Aurolife Pharma, LLC · 2400 US Highway 130 · Dayton, NJ · 08810-1519

Is this the product you have?

    • Fexofenadine Hydrochrloride Tablets USP
    • 180 mg
    • 100-count bottle
  • Distributed by
    • Aurohealth LLC
    • 2572 Brunswick Pike
    • Lawrenceville
    • NJ 08648
    • NDC 58602-711-21
Lot codes and dates
    • Lot #: 067180008A
    • Exp 03/21
Amount recalled
8,240 bottles

This recall covers 11 products

The agency filed one notice per product. You are reading one of them; the other 10 are below.

Where it was sold

  • Nationwide

Why it was recalled

Failed Impurities/Degradation Specifications

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Aurolife Pharma, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 16, 2022 · Data as of Sep 19, 7:21 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.